Inventor · disambiguated record
Martin Knobloch
Also filed as: KNOBLOCH MARTIN
3 granted patents·8 pending applications·25 citations·filing 2007–2023
69Inventor score
Top patents by PatentIndex Score
11 records- 0181US8841303B2Melt-processed imatinib dosage formBreitenbach Jörg·Filed 2007·Granted Sep 23, 2014·17 cites·17 claims
- 0279US2024197757A1Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitorABBVIE DEUTSCHLAND·Filed 2023·Application pending·0 cites
- 0373US8337733B2Preparation of compositions with essentially noncrystalline embedded macrolide antibioticsWESTEDT ULRICH·Filed 2008·Granted Dec 25, 2012·6 cites·19 claims
- 0472US2022110951A1Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitorABBVIE DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 0570US2021093649A1Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitorABBVIE DEUTSCHLAND·Filed 2020·Application pending·0 cites
- 0668US9642796B2Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitorPACKHAEUSER CLAUDIA·Filed 2010·Granted May 9, 2017·2 cites·22 claims
- 0763US2019269704A1Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitorABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 0857US2017189426A1Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitorABBVIE INC·Filed 2017·Application pending·0 cites
- 0955US2009274731A1Production of enveloped pharmaceutical dosage formsABBOTT GMBH & CO KG·Filed 2007·Application pending·0 cites
- 1046US2010143459A1Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitorABBOTT GMBH & CO KG·Filed 2007·Application pending·0 cites
- 1137US2010297194A1Formulation for oral administration of apoptosis promoterCATRON NATHANIEL·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →